Online first
Short communication
Published online: 2024-10-29
30-day mortality and mortality-related risk factors in the Polish cohort undergoing catheter ablation of the accessory pathway between 2010 and 2020
Pubmed: 39535957
Abstract
Not available
References
- Bunch TJ, May HT, Bair TL, et al. Long-term natural history of adult wolff-parkinson-white syndrome patients treated with and without catheter ablation. Circ Arrhythm Electrophysiol. 2015; 8(6): 1465–1471.
- Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999; 99(2): 262–270.
- Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020; 41(5): 655–720.
- Holmqvist F, Kesek M, Englund A, et al. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J. 2019; 40(10): 820–830.
- Brado J, Hochadel M, Senges J, et al. Outcomes of ablation in Wolff-Parkinson-White-syndrome: Data from the German Ablation Registry. Int J Cardiol. 2021; 323: 106–112.
- Pappone C, Vicedomini G, Manguso F, et al. Wolff-Parkinson-White syndrome in the era of catheter ablation: Insights from a registry study of 2169 patients. Circulation. 2014; 130(10): 811–819.
